Evidence map›Paper›PMID 24876913›Full record

ReviewOxidative medicine and cellular longevity2014

Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Giovanni Pagano, Annarita Aiello Talamanca, Giuseppe Castello, Mario D Cordero, Marco d'Ischia, Maria Nicola Gadaleta, Federico V Pallardó, Sandra Petrović, Luca Tiano, Adriana Zatterale

Abstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Actives from the Micro-Immunotherapy Medicine 2LMIREGJournal of inflammation research · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giovanni PaganoCancer Research Centre at Mercogliano (CROM), Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, 80131 Naples, Italy.ORCID 0000-0001-6166-2620
Annarita Aiello TalamancaCancer Research Centre at Mercogliano (CROM), Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, 80131 Naples, Italy.ORCID 0000-0001-9539-0205
Giuseppe CastelloCancer Research Centre at Mercogliano (CROM), Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, 80131 Naples, Italy.ORCID 0000-0002-0924-6248
Mario D CorderoResearch Laboratory, Dental School, Sevilla University, 41009 Sevilla, Spain.ORCID 0000-0003-0151-3644
Marco d'IschiaDepartment of Chemical Sciences, Federico II University, 80126 Naples, Italy.
Maria Nicola GadaletaNational Research Council, Institute of Biomembranes and Bioenergetics, 70126 Bari, Italy.
Federico V PallardóCIBERER, University of Valencia-INCLIVA, 46010 Valencia, Spain.
Sandra Petrović"Vinca" Institute of Nuclear Sciences, University of Belgrade, 11070 Belgrade, Serbia.
Luca TianoDepartment of Clinical and Dental Sciences, Polytechnical University of Marche, 60100 Ancona, Italy.
Adriana ZatteraleDepartment of Genetics, ASL Napoli 1, 80136 Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beyond the disorders recognized as mitochondrial diseases, abnormalities in function and/or ultrastructure of mitochondria have been reported in several unrelated pathologies. These encompass ageing, malformations, and a number of genetic or acquired diseases, as diabetes and cardiologic, haematologic, organ-specific (e.g., eye or liver), neurologic and psychiatric, autoimmune, and dermatologic disorders. The mechanistic grounds for mitochondrial dysfunction (MDF) along with the occurrence of oxidative stress (OS) have been investigated within the pathogenesis of individual disorders or in groups of interrelated disorders. We attempt to review broad-ranging pathologies that involve mitochondrial-specific deficiencies or rely on cytosol-derived prooxidant states or on autoimmune-induced mitochondrial damage. The established knowledge in these subjects warrants studies aimed at elucidating several open questions that are highlighted in the present review. The relevance of OS and MDF in different pathologies may establish the grounds for chemoprevention trials aimed at compensating OS/MDF by means of antioxidants and mitochondrial nutrients.

Indexed as

Oxidative StressAgingAutoimmune DiseasesHumansMitochondriaMitochondrial DiseasesNeoplasmsNeurodegenerative Diseases

Identifiers

PMID24876913
PMCPMC4024404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.